Alzheimer's Research May Be Missing Key Patterns by Treating All Cases Alike

A new analysis warns that combining diverse Alzheimer's cases in research studies could obscure important biological differences that affect treatment outcomes. The finding challenges how the field designs trials and pools data, potentially explaining why some drugs fail and suggesting pharmaceutical and health policy decision-makers need more precise patient categorization strategies.

Originaltitel: Pooling Alzheimer’s disease: when methodological rigor risks obscuring biological complexity